Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Amgen, Assoc, begun, cGLP, divergence, fill, inter, junior, lab, overextend, overworked, payload, primate, reprioritization, Topic, turnover, unvaried
Removed:
AHR, antagonist, aryl, ASUNo, caseAmgen, certificate, Certification, complement, dated, execute, Exhibit, formatted, Furnished, genome, goal, herewith, hydrocarbon, includinginter, incorporation, Inline, line, Linkbase, Mahoney, molecule, noted, Page, Presentation, prioritized, qualitative, quantitative, registrant, restated, Schema, selectively, simultaneously, Specimen, Stephen, taxonomy, thereunto, unclear, undersigned, unproductive, XBRL
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view